Using AI for personalized breast cancer risk assessment: An important tool for early detection

November 29, 2024

Finally, selecting an AI vendor for breast imaging committed to continuous innovation in personalized cancer screening is essential to prevent technological obsolescence. A vendor focused on long-term program success, not just algorithms, ensures you deliver cutting-edge care while fostering a partnership invested in improving patient outcomes.

About the author: Lester Litchfield is the head of data science for Volpara Health, a Lunit company.

Back to HCB News

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!